DWG-93560-41340
3 vaccinations
4 coded responses
38 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 322 / FL
- Registered
- 2021-02-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-02
Registered in v-safe
-
2021-02-02
Dose 1 — Pfizer-BioNTech
- 2021-02-02
-
2021-02-03
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-04
-
2021-02-05
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
-
2021-02-16
Survey response — day 14, dose 1MedDRA: Oropharyngeal pain — Feeling: FairFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-23
Dose 2 — Pfizer-BioNTech
- 2021-02-23
- 2021-02-23
-
2021-02-24
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-03-01
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-03-23
- 2021-03-30
- 2021-04-08
-
2021-05-25
Survey response — 3 months, dose 2MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: FairFree text: Congested and runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-24
-
2021-11-22
Dose 3 — Pfizer-BioNTech
- 2021-11-22
-
2021-11-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-24
- 2021-11-25
- 2021-11-26
- 2021-11-28
- 2021-11-29
- 2021-12-06
- 2021-12-13
-
2021-12-20
Survey response — day 28, dose 3MedDRA: Paranasal sinus discomfort — Feeling: GoodFree text: Sinus pressureMedDRA releases: 2024-11 · check-in free text available
- 2021-12-27
- 2022-01-03
- 2022-02-23
-
2022-11-22
Survey response — 12 months, dose 3MedDRA: Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: CongestionMedDRA releases: 2024-11 · check-in free text available
-
2022-11-22
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-11-23
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-02 | Pfizer-BioNTech | |
| 2 | 2021-02-23 | Pfizer-BioNTech | |
| 3 | 2021-11-22 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 4 — day 14, dose 1
Symptoms: Sore throat
Release 8 — 3 months, dose 2
Symptoms: Congested and runny nose
Release 10 — day 28, dose 3
Symptoms: Sinus pressure
Release 12 — 12 months, dose 3
Symptoms: Congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release